In gastric cancer, Reg1α promoted angiogenesis via the classical Akt and Erk signaling pathways [86], while Reg3A enhanced cell viability and drug resistance in ovarian cancer by activating the Akt signaling pathway [93]. Here, REG1A is linked to ovarian carcinoma.